A Primer on Cellular Therapy

The treatment approach has taken aim at its first retinal disease: CMV reti…

Read Article
  • AMD Disease Education Resource Center

    Read Article
  • Steroid Delivery in Patients With Diabetic Macular Edema in the Presence of a Cataract

    Read Article
  • DRCR.net Protocol Review

    Read Article


Visit @RetinaToday on Twitter

Articles From This Issue


A Primer on Cellular Therapy

COVER FOCUS: Advances in Retina Medicine

Traditional therapies for treatment of retinal diseases have centered around surgery, laser, and related approaches, but the past decade has seen a shift toward targeted m…

Breakthrough Treatment Modalities for Hereditary Retinal Diseases

Inherited retinal diseases (IRDs) are a heterogeneous group of dystrophies that produce a spectrum of visual impairment and blindness. Before modern treatments became avai…

  • AMD Awareness Month
  • DME Disease Education Resource Center
  • Uveitis Resource Center
  • ZEISS OCT Angiography eNewsletter Series
  • AMD Disease Education Resource Center
  • NEWS


    Regeneron Announces US Prescribing Information Clarification for Eylea Injection

    Regeneron Pharmaceuticals announced that the FDA has approved an update to the dosage and administra…

    Alimera Sciences' Iluvien Data Presented at ARVO

    Alimera Sciences announced that data from seven Iluvien post marketing studies were presented during…

    Video Series

    Contact Info

    Bryn Mawr Communications LLC
    1008 Upper Gulph Road, Suite 200
    Wayne, PA 19087

    Phone: 484-581-1800
    Fax: 484-581-1818

    Karen Roman

    Janet Burk

    About Retina Today

    Retina Today is a publication that delivers the latest research and clinical developments from areas such as medical retina, retinal surgery, vitreous, diabetes, retinal imaging, posterior segment oncology and ocular trauma. Each issue provides insight from well-respected specialists on cutting-edge therapies and surgical techniques that are currently in use and on the horizon.